Axogen, Inc.
13631 Progress Boulevard
Suite 400
Alachua
Florida
32615
United States
Tel: 888-296-4361
Fax: 386-462-6801
Website: http://www.axogeninc.com/
237 articles about Axogen, Inc.
-
AxoGen, Inc. Release: Significant U.S. Peripheral Nerve Repair Market Opportunity Highlighted in New Independent Research
9/20/2013
-
AxoGen, Inc. Announces Exercise of Over-Allotment Option
9/11/2013
-
AxoGen, Inc. Closes $18 Million Offering and Moves to NASDAQ
8/15/2013
-
AxoGen, Inc. Announces Pricing of $18 Million Underwritten Offering and Uplisting to NASDAQ
8/9/2013
-
Recipient of Leg Saving Surgery With AxoGen, Inc.'s Avance® Nerve Graft Selected to Participate in 2014 Rose Parade
7/30/2013
-
AxoGen, Inc. Reports Second Quarter 2013 Financial Results
7/11/2013
-
AxoGen, Inc. Announces 2013 Annual Shareholders' Meeting
6/26/2013
-
AxoGen, Inc. Announces Health Canada Approval for AxoGuard® Nerve Connector and AxoGuard® Nerve Protector
6/4/2013
-
AxoGen, Inc. Announces Presentation of Avance® Nerve Graft Data at the 18th Federation of European Societies for Surgery of the Hand Congress
5/29/2013
-
AxoGen, Inc. Receives Grant in Partnership With Vanderbilt University From U.S. Department of Defense
5/23/2013
-
AxoGen, Inc. Announces Release Date of First Quarter 2013 Results and Conference Call
4/24/2013
-
AxoGen, Inc. Announces Release Date of 2012 Fourth Quarter & Year End Results and Conference Call
2/27/2013
-
AxoGen, Inc. to Present at Noble Financial Equity Conference
1/15/2013
-
AxoGen, Inc. Announces Third Quarter 2012 Financial Results
11/7/2012
-
AxoGen, Inc. Announces Release Dates for 2012 Third Quarter Results and Conference Call
10/26/2012
-
AxoGen, Inc. Completes $20.8 Million Financing With PDL BioPharma, Inc.
10/10/2012
-
AxoGen, Inc. to Present at the Craig-Hallum Alpha Select Conference
9/20/2012
-
AxoGen, Inc. to Present at Noble Financial Life Sciences Conference
9/11/2012
-
AxoGen, Inc. Reports Record Second Quarter 2012 Revenues
8/15/2012
-
AxoGen, Inc. Announces Release Date of 2012 Second Quarter Results and Conference Call
8/1/2012